Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis.
about
Preventive treatments for breast cancer: recent developmentsTiming of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON studyContralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriersCurrent condition of genetic medicine for hereditary breast cancer.BRCA1 and BRCA2 mutations and treatment strategies for breast cancer.High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer.Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.Impact of Prophylactic Mastectomy in BRCA1/2 Mutation CarriersContralateral risk-reducing mastectomy: review of risk factors and risk-reducing strategies.Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias.The Manchester guidelines for contralateral risk-reducing mastectomyThe prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancerBilateral Mastectomy for Unilateral Breast Cancer: a Perplexing TrendContralateral prophylactic mastectomy and its impact on quality of lifeAttitudes to contralateral risk reducing mastectomy among breast and plastic surgeons in England.Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer.A prior diagnosis of breast cancer is a risk factor for breast cancer in BRCA1 and BRCA2 carriers.Genetic testing today.Ethics and genomic medicine, how to navigate decisions in surgical oncology.Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers.The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients.Women at familial risk of breast cancer electing for prophylactic mastectomy: frequencies, procedures, and decision-making characteristics.The Role of Knowledge on Genetic Counseling and Testing in Black Cancer Survivors at Increased Risk of Carrying a BRCA1/2 Mutation.Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.Local Recurrence and Breast Oncological Surgery in Young Women With Breast Cancer: The POSH Observational Cohort Study.Assessing, Counseling, and Treating Patients at High Risk for Breast Cancer.Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2015 edition.Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? results from a randomized clinical trial.Negative Genetic Testing Does Not Deter Contralateral Prophylactic Mastectomy in Younger Patients with Greater Family Histories of Breast Cancer.Preoperative genetic testing impacts surgical decision making in BRCA mutation carriers with breast cancer: a retrospective cohort analysisRisk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis.Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer.Survival analysis of contralateral prophylactic mastectomy: a question of selection bias.Integrating surgery and genetic testing for the modern surgeon.Evaluation of Breast Cancer Patients with Genetic Risk in a University Hospital: Before and After the Implementation of a Heredofamilial Cancer Unit.Local delivery of hormonal therapy with silastic tubing for prevention and treatment of breast cancer.Short report: Follow-up of Bahamian women with a BRCA1 or BRCA2 mutation.
P2860
Q27025375-B0F9926F-9CDB-4D11-8B3B-D3F29284F432Q30896495-B2DCC0D0-07CF-4A97-B774-2A4B6758FCA3Q31118195-860D77D6-C237-434D-888A-84887175F147Q33823472-90796F51-0864-4319-BF9D-EFE3375821B8Q33858408-55E9F08E-515F-46EB-B4C8-B885A9F055A8Q33894431-A1EE3449-50D8-402B-8BD1-B47AA1289F58Q34240064-4A619D9D-3432-402F-B419-25C471766CD2Q34996647-A8CDD57C-3BE0-4089-8020-D00C319E7A4EQ35050959-662DCE9A-EACE-4616-AF6D-801AB0E0DDE9Q35066801-3E883F8A-3B9A-45D6-A68C-F4A5BED9B2DEQ35850183-D4E57BE3-CE54-4F84-A340-A00244CC607EQ35923270-4425DC58-9AB2-451D-8616-E404F96AA018Q35940364-56C55BF4-7BD5-4C7A-875F-1E12EE5B454AQ36734744-47EE5397-115C-4D63-ABAB-7F8B8D3DB070Q37147521-C536D62B-5290-4250-B3CE-9C77D237F0F9Q37556568-21D444BF-AEE0-426E-AE56-314249AF85A6Q37710168-60D122E1-B268-4B37-BC07-049D1CA81E1AQ37719595-A98A6D55-94C9-4A2A-B214-D41247403121Q38230196-DD69D286-5376-4DCF-8281-1AEF65D244DBQ38245663-FBFCB67C-AD40-488B-A59B-29F0A4400A00Q38378750-C76F570C-D191-468D-B0CC-6CF64B0809C1Q38777240-F7F96A3E-1F73-4E2C-9F26-6A8C81CD664AQ38821731-F89C9034-06ED-46D5-A691-BD45D718FB0DQ38842957-932D48DF-B76D-4CC3-B418-A370B4C8DF1AQ38846562-51A7978F-C7C2-4099-A70E-E13CA43CED7FQ39150355-2928F3C2-264C-4CBF-9895-E24B6A546633Q39562817-BB06E068-3A88-4D4A-8DFF-C75800E71396Q39612960-82782D1F-F2CE-4606-9D57-215EA65E468BQ39659182-66B52111-C433-4F8E-8F39-9AFC94ECF434Q40912150-E34E841B-8E32-4F18-8179-1B3E6DA29E87Q41024301-E947D9C2-E3BD-4397-A6F2-3E3115509556Q41088085-5C0BD1D1-A36D-424B-8D71-AFB74ED96AB2Q41146968-8A1BF939-EDC6-4C21-B0E5-DB678EBC5EF0Q41517367-9AF445D2-7C71-4D5D-A5C3-AB819D225A78Q44429695-EF9EF75D-CFED-427D-9AEF-6A8E9637519DQ46442172-6E8AE1BE-3CEF-4F45-9E28-92637ECAF20BQ47117168-CD3F4B0C-F14F-4FEF-990F-FE246A9190BCQ47191699-E680FB67-4298-4BF4-82C2-E38FC11EF4AEQ47192770-639C7108-E530-4868-9D99-F817BFAB3F95Q47561619-B68BB0B8-62F6-4C6A-922D-CE66C00C5108
P2860
Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Contralateral mastectomy and s ...... tions: retrospective analysis.
@en
Contralateral mastectomy and s ...... tions: retrospective analysis.
@nl
type
label
Contralateral mastectomy and s ...... tions: retrospective analysis.
@en
Contralateral mastectomy and s ...... tions: retrospective analysis.
@nl
prefLabel
Contralateral mastectomy and s ...... tions: retrospective analysis.
@en
Contralateral mastectomy and s ...... tions: retrospective analysis.
@nl
P2093
P2860
P356
P1433
P1476
Contralateral mastectomy and s ...... tions: retrospective analysis.
@en
P2093
Andrea Eisen
Barry Rosen
Carrie Snyder
Charmaine Kim-Sing
Henry T Lynch
Kelly Metcalfe
Nadine Tung
Parviz Ghadirian
Shelley Gershman
P2860
P356
10.1136/BMJ.G226
P407
P577
2014-02-11T00:00:00Z